Cargando…

Exposure to cisplatin in the operating room during hyperthermic intrathoracic chemotherapy

PURPOSE: Hyperthermic intrathoracic chemotherapy (HITOC) is an additive, intraoperative treatment for selected malignant pleural tumors. To improve local tumor control, the thoracic cavity is perfused with a cisplatin-containing solution after surgical cytoreduction. Since cisplatin is probably carc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Markowiak, Till, Ried, Michael, Larisch, Christopher, Nowak, Dennis, Hofmann, Hans-Stefan, Rakete, Stefan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8795016/ https://www.ncbi.nlm.nih.gov/pubmed/34191089 http://dx.doi.org/10.1007/s00420-021-01738-3

Ejemplares similares

The Excretion of Cisplatin after Hyperthermic Intrathoracic Chemotherapy
por: Larisch, Christopher, et al.
Publicado: (2023)

Hyperthermic intrathoracic chemotherapy (HITHOC): narrative review of the current literature, recommendations and future studies
por: Markowiak, Till, et al.
Publicado: (2021)

Protocol of a retrospective, multicentre observational study on hyperthermic intrathoracic chemotherapy in Germany
por: Markowiak, Till, et al.
Publicado: (2020)

Assessment of concentration and penetration depth of cisplatin in human lung tissue after decortication and hyperthermic exposure
por: Larisch, Christopher, et al.
Publicado: (2021)

Surgical cytoreduction and hyperthermic intrathoracic chemotherapy for thymic tumours with pleural spread is effective on survival: results from the multicentre German hyperthermic intrathoracic chemotherapy study
por: Ried, Michael, et al.
Publicado: (2023)

Anaesthetic management of cytoreductive surgery followed by hyperthermic intrathoracic chemotherapy perfusion
por: Kerscher, Christoph, et al.
Publicado: (2014)

Hyperthermic Intrathoracic Chemotherapy (HITOC) after Cytoreductive Surgery for Pleural Malignancies—A Retrospective, Multicentre Study
por: Ried, Michael, et al.
Publicado: (2021)

Hyperthermic intrathoracic chemotherapy (HITHOC) should be included in the guidelines for malignant pleural mesothelioma
por: Migliore, Marcello, et al.
Publicado: (2021)

Hyperthermic intrathoracic chemotherapy with cisplatin for ovarian cancer with pleural metastasis
por: Jun, Su Youn, et al.
Publicado: (2017)

Pharmacokinetics of Hyperthermic Intrathoracic Chemotherapy following Pleurectomy and Decortication
por: Sugarbaker, Paul H., et al.
Publicado: (2012)

Classification and staging of thymoma
por: Markowiak, Till, et al.
Publicado: (2020)

Cytoreductive onco-surgery with combined hyperthermic intraperitoneal chemotherapy and hyperthermic intrathoracic chemotherapy: Perioperative challenges
por: Dattatri, Rohini, et al.
Publicado: (2019)

Cardiac output and oxygen delivery are affected by intraoperative hyperthermic intrathoracic chemotherapy
por: Scolletta, S, et al.
Publicado: (2008)

Anaesthetic management of extra-pleural pneumonectomy and hyperthermic intrathoracic chemotherapy procedure
por: Ramegowda, Jalaja Koppa, et al.
Publicado: (2015)

A narrative review of hyperthermic intrathoracic chemotherapy for advanced lung cancer
por: Song, Kimberly, et al.
Publicado: (2021)

Present and future of hyperthermic intrathoracic chemotherapy (HITHOC) in thoracic surgical oncology
por: Migliore, Marcello
Publicado: (2021)

Salvage debulking surgery and hyperthermic intrathoracic chemotherapy for massive recurrent mesothelioma in the mediastinum
por: Poon, Shi Sum, et al.
Publicado: (2022)

Hyperthermic Intrathoracic Chemotherapy for Malignant Pleural Mesothelioma: The Forefront of Surgery-Based Multimodality Treatment
por: Aprile, Vittorio, et al.
Publicado: (2021)

Effect of hyperthermic intrathoracic chemotherapy on the malignant pleural mesothelioma: a systematic review and meta-analysis
por: Zhao, Zi-Yi, et al.
Publicado: (2017)

Some like it hot: the potential role of hyperthermic intrathoracic chemotherapy in the multimodality treatment of pleural mesothelioma
por: Branch, Kevin, et al.
Publicado: (2023)

Efficacy of hyperthermic intrathoracic chemotherapy for initially diagnosed lung cancer with symptomatic malignant pleural effusion
por: Li, Zihui, et al.
Publicado: (2023)

Intraoperative Contrast-Enhanced Ultrasonography (Io-CEUS) in Minimally Invasive Thoracic Surgery for Characterization of Pulmonary Tumours: A Clinical Feasibility Study
por: Schauer, Martin Ignaz, et al.
Publicado: (2023)

Video-assisted pulmonary metastectomy is equivalent to thoracotomy regarding resection status and survival
por: Markowiak, Till, et al.
Publicado: (2021)

Effect of hyperthermic intrathoracic chemotherapy (HITHOC) on the malignant pleural effusion: A systematic review and meta-analysis
por: Zhou, Hua, et al.
Publicado: (2017)

Evaluation of Surgical Therapy in Advanced Thymic Tumors
por: Markowiak, Till, et al.
Publicado: (2021)

Short-term and long-term outcomes of intrathoracic vacuum therapy of empyema in debilitated patients
por: Sziklavari, Zsolt, et al.
Publicado: (2016)

A Dose-Finding Trial for Hyperthermic Intraperitoneal Cisplatin in Gynecological Cancer Patients Receiving Hyperthermic Intraperitoneal Chemotherapy
por: Chan, Chui-ying, et al.
Publicado: (2021)

The addition of sodium thiosulphate to hyperthermic intraperitoneal chemotherapy with cisplatin in ovarian cancer
por: Glennon, Kate, et al.
Publicado: (2021)

Hyperthermic Intrathoracic Chemoperfusion for Malignant Pleural Mesothelioma: Systematic Review and Meta-Analysis
por: Järvinen, Tommi, et al.
Publicado: (2021)

Effect of Cilastatin on Cisplatin-Induced Nephrotoxicity in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy
por: Zaballos, Matilde, et al.
Publicado: (2021)

Intrathoracic aerosol chemotherapy via spray-catheter
por: Khosrawipour, Veria, et al.
Publicado: (2020)

Cytoreductive surgery and Hyperthermic intra-operative peritoneal chemotherapy with Cisplatin for gastric peritoneal Carcinomatosis Monocentric phase-2 nonrandomized prospective clinical trial
por: Topal, Baki, et al.
Publicado: (2017)

Hyperthermic intrathoracic chemotherapy for the treatment of malignant pleural effusion caused by breast and ovarian cancer: A systematic literature review and pooled analysis
por: Karampinis, Ioannis, et al.
Publicado: (2022)

Postoperative outcome after palliative treatment of malignant pleural effusion
por: Markowiak, Till, et al.
Publicado: (2022)

Calculating the dose of cisplatin that is actually utilized in hyperthermic intraperitoneal chemotherapy among ovarian cancer patients
por: Wang, Wu-yun, et al.
Publicado: (2021)

Intrathoracic gastric volvulus as a severe, delayed surgical complication after left subphrenic peritonectomy and hyperthermic intraperitoneal chemotherapy (HIPEC) for advanced ovarian cancer
por: Caronna, Roberto, et al.
Publicado: (2013)

Hyperthermic Intraoperative Thoracoabdominal Chemotherapy
por: Sugarbaker, Paul H., et al.
Publicado: (2012)

Hyperthermic intrapleural chemotherapy: an update
por: Campany, Megan E., et al.
Publicado: (2023)

Systemic complications of the bidirectional intraoperative chemotherapy with intravenous ifosfamide and hyperthermic intraperitoneal chemotherapy (HIPEC) using cisplatin plus doxorubicin
por: Hakeam, Hakeam, et al.
Publicado: (2019)

Mechanism of hyperthermic potentiation of cisplatin action in cisplatin-sensitive and -resistant tumour cells.
por: Hettinga, J. V., et al.
Publicado: (1997)

Cannot write session to /tmp/vufind_sessions/sess_smgb2fnfies9bqbghvkhn5dluo